High Efficiency of Kanakinumabum for a Patient with a Late Diagnosed Chronic Infantile Neurological Cutaneous Articular Syndrome (CINCA)

• Egile Nagusiak: T. V. Sleptsova (Egilea), E. I. Alekseeva (Egilea), K. V. Savostianov (Egilea), A. A. Pushkov (Egilea), T. M. Bazarova (Egilea), S. I. Valieva (Egilea), O. L. Lomakina (Egilea), R. V. Denisova (Egilea), K. B. Isaeva (Egilea), E. G. Chistyakova (Egilea)
• Formatua: Liburua
• Argitaratua: Union of pediatricians of Russia, 2015-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The article presents the monitoring of a severe course of CINCA/NOMID syndrome diagnosed at late stages. The use of monoclonal antibodies to IL 1 - kanakinumabum - in a patient with chronic neurological cutaneous and articular syndrome was successful: fever, cutaneous and pain syndromes were complet...